M&A
confidence high
sentiment neutral
materiality 0.50
FOXO signs non-binding deal to acquire Vector Biosource for up to $1.5M in preferred stock
FOXO TECHNOLOGIES INC.
- Purchase price includes $750K Series D Preferred at close, plus $750K upon 2025 milestones.
- Earnout payments in Series D Preferred based on 2026-2027 revenues and cash collections.
- Vector expects $800K revenue in 2025; closing subject to definitive agreements within 45 days.
- Transaction requires $1M working capital, due diligence, and other customary conditions.